Shanghai Abbott Pharmaceutical Co.
No.1288, Wusi Highway, Haiwan Town, Fengxian District,
Shanghai, 201422,
China
Shanghai, 201422,
China
86 21 5716 3827
Life Sciences
Shanghai Abbott Pharmaceutical Co. Technographics
Shanghai Abbott Pharmaceutical Co. Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Shanghai Abbott Pharmaceutical Co. and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 80 Shanghai Abbott Pharmaceutical Co. employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Shanghai Abbott Pharmaceutical Co. has purchased the following applications: UKG Great Place to Work Emprising for Employee Experience, Employee Engagement in 2020, YUEMIA MedChat for Chatbots and Conversational AI in 2016, Adobe Experience Manager for Digital Asset Management in 2020 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Shanghai Abbott Pharmaceutical Co. is running and its propensity to invest more and deepen its relationship with UKG , YUEMIA , Adobe Systems or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Shanghai Abbott Pharmaceutical Co. revenues, which have grown to $8.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Shanghai Abbott Pharmaceutical Co. intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Shanghai Abbott Pharmaceutical Co. Tech Stack and Enterprise Applications
Shanghai Abbott Pharmaceutical Co. HCM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| UKG | Legacy | UKG Great Place to Work Emprising | Employee Experience, Employee Engagement | HCM | n/a | 2020 | 2022 |
In 2020, Shanghai Abbott Pharmaceutical Co. deployed UKG Great Place to Work Emprising to support its Employee Experience,Employee Engagement initiatives. The implementation is visible on the company website where UKG Great Place to Work Emprising is used to present employer branding content alongside engagement touchpoints.
The deployment centers on engagement survey capabilities, configured survey cadences, and analytics dashboards to capture employee sentiment and participation trends consistent with Employee Experience,Employee Engagement use cases. Configuration work emphasized role based access for HR and leadership, predefined survey templates, and public certification content surfaced through the web presence.
Operational ownership is concentrated in HR and corporate communications, with governance focused on scheduled survey distribution, defined reporting workflows, and content management for the website display. Rollout activity oriented the application for an 80 person organization scale, aligning survey administration and dashboard access with people operations and senior leadership review.
|
Shanghai Abbott Pharmaceutical Co. AI-Powered Application
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| YUEMIA | Legacy | YUEMIA MedChat | Chatbots and Conversational AI | AI-Powered Application | n/a | 2016 | 2016 |
In 2016 Shanghai Abbott Pharmaceutical Co. deployed YUEMIA MedChat to support medical marketing, physician engagement and patient-education workflows across China. YUEMIA MedChat is a Chatbots and Conversational AI application used to expand digital outreach and help reduce field-marketing costs by automating routine engagement and educational interactions.
The implementation centered on the MedChat conversational module, configured to deliver multi-role conversational flows for physicians and patients and to sequence educational content for patient-education workflows. Functional capabilities implemented included automated question and answer handling, scheduled messaging for campaign orchestration, and content management for clinical and promotional materials, aligned with medical marketing use cases. Configuration emphasized role-based content delivery and conversational logic to route inquiries to appropriate follow up channels when needed.
Operational coverage spanned national field-marketing teams and digital engagement channels across China, with primary business functions impacted including medical affairs, marketing, and patient support. Governance and process alignment focused on content oversight between medical affairs and marketing to ensure consistent clinical messaging and regulatory compliance. Vendor materials cite outcomes of expanded digital outreach and reduced field-marketing costs as justification for the deployment of YUEMIA MedChat.
|
Shanghai Abbott Pharmaceutical Co. Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Adobe Systems | Legacy | Adobe Experience Manager | Digital Asset Management | Content Management | n/a | 2020 | 2020 |
In 2020, Shanghai Abbott Pharmaceutical Co. implemented Adobe Experience Manager to provide Digital Asset Management capabilities for its corporate website. The deployment focuses on centralizing web assets and supporting site publication of imagery, documents and marketing creatives through a unified asset store.
Adobe Experience Manager was configured to deliver a central asset repository, metadata taxonomy and rendition management consistent with Digital Asset Management functional workflows. Editorial authoring and approval workflows were established to control publishing, and automation of asset renditions and basic workflow orchestration were applied in line with typical AEM capabilities.
The implementation is integrated directly into the corporate web content delivery flow, enabling site editors to publish assets from the Adobe Experience Manager repository to web pages. Operational coverage centers on the marketing and web teams responsible for site content, with asset governance and permissioning scoped to those business functions.
Governance emphasizes metadata standards, role based access control and editorial approval steps to manage asset lifecycle and web publication. The configuration centralizes digital assets and aligns asset management processes with site authoring workflows to support ongoing content operations.
|
Shanghai Abbott Pharmaceutical Co. CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Customer Experience | CRM |
|
2018 | 2018 |
|
|
|
|
|
Data Management Platform | CRM |
|
2020 | 2020 |
|
|
|
|
|
Marketing Analytics | CRM |
|
2020 | 2020 |
|
|
|
|
|
Marketing Analytics | CRM |
|
2021 | 2021 |
|
|
|
|
|
Marketing Automation | CRM |
|
2018 | 2018 |
|
|
|
|
|
Tag Management | CRM |
|
2020 | 2020 |
|
Shanghai Abbott Pharmaceutical Co. ITSM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Performance Management | ITSM |
|
2022 | 2022 |
|
Shanghai Abbott Pharmaceutical Co. PaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Master Data Management | PaaS |
|
2019 | 2019 |
|
Shanghai Abbott Pharmaceutical Co. IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2020 | 2020 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2022 | 2022 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2022 | 2022 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2021 | 2021 |
|
IT Decision Makers and Key Stakeholders at Shanghai Abbott Pharmaceutical Co.
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Shanghai Abbott Pharmaceutical Co. Executives
APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Shanghai Abbott Pharmaceutical Co. IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Shanghai Abbott Pharmaceutical Co. digital transformation priorities and AI adoption trends.
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD Shanghai Abbott Pharmaceutical Co. Technographics
Shanghai Abbott Pharmaceutical Co. is a Life Sciences organization based in China,
with around 80 employees and annual revenues of $8.0 million.
Shanghai Abbott Pharmaceutical Co. operates a diverse technology stack with applications such as
UKG Great Place to Work Emprising, YUEMIA MedChat and Adobe Experience Manager,
covering areas like Employee Experience, Employee Engagement, Chatbots and Conversational AI and Digital Asset Management.
Shanghai Abbott Pharmaceutical Co. has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as UKG, YUEMIA and Adobe Systems.
Shanghai Abbott Pharmaceutical Co. recently adopted applications including
New Relic APM in 2022, Fastly in 2022 and Amazon CloudFront in 2022,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Shanghai Abbott Pharmaceutical Co.’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates Shanghai Abbott Pharmaceutical Co.’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Shanghai Abbott Pharmaceutical Co. technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.